ION BEAM Aktie

 

Im schwachen Gesamtmarkt präsentiert sich die Aktie von Ion Beam Applications in einer starken Verfassung. Auch zum Start in die neue Handelswoche zeichnen sich im frühen Handel weitere Kursgewinne beim europäischen Nebenwert ab. Kein Wunder, konnten die Belgier einen weiteren nennenswerten Auftrag aus den USA an Land ziehen....

Louvain-La-Neuve, Belgium, June 08, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces the signing of a contract with Duke University Health System for the installation of two Proteus®ONE1 compact proton therapy solutions at the Duke Proton Center in Durham, NC, USA....

Louvain-la-Neuve, Belgium, June 1st, 2026 – 9 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium – 01 June 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today launches Cyclone® iKure, a dedicated cyclotron for routine Astatine-211 (At-211) production. Designed for alpha-beam irradiation, this new cyclotron enables radiopharmaceutical manufacturers, research institutions and healthcare providers to accelerate access to targeted alpha therapies with the reliability and quality required for clinical-scale programs....

Louvain-la-Neuve, Belgium, May 26th, 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026....

Louvain-la-Neuve, Belgium, May 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today the launch of Rhodotron® LITE, a new low-power X-ray accelerator. This launch expands IBA's industrial X-ray portfolio into the low-capacity segment, enabling a broader range of operators to access X-ray irradiation technology at a time when supply security, operational flexibility and long-term sustainability are becoming increasingly strategic for sterilisation and food irradiation value chains....

Louvain-la-Neuve, Belgium, May 19th, 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, May 11th, 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, May 5th, 2026 – 6:30 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, April 27th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, April 20th, 2026 – 9 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, April 13th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

US Nuclear Fusion Startup To Build Radioactive Batteries For Use In Space Authored by Ameya Paleja via Interesting Engineering, Avalanche Energy, a fusion energy startup, has won a $5.2 million contract to build radioactive batteries that can power a laptop-class system for months. The contract is part of the Defense Advanced Research Projects Agency's Rads to Watts Program, which aims to build next-generation, compact, resilient nuclear batteries with higher densities.  An early prototype of Avalanche Energy's radiovoltaic converter for the DARPA Rads to Watts program is exposed to high-energy ion-beam irradiation.Avalanche Fusion Radioactive batteries aren't an entirely new concept. They have been around for years and have made their way even to Mars on NASA's Perseverance and Curiosity rovers. Another type of radioactive battery is used in medical implant devices and sensors, but all these devices face the same issue: low energy density.  Lithium-ion batteries, which are used everywhe...

Louvain-la-Neuve, Belgium, April 7th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Louvain-la-Neuve, Belgium, March 30th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical production solutions, today announced it has signed a contract with Telix Pharmaceuticals Limited (Telix; ASX: TLX, NASDAQ: TLX), a precision oncology company, for the initial order of four Cyclone® KIUBE cyclotrons at standard IBA conditions1. The systems will be installed at select RLS Radiopharmacies (RLS) sites in the United States (U.S.)....

Louvain-la-Neuve, Belgium, February 23rd, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....

Das belgische Medizintechnik-Unternehmen ist ein wahrer Hidden Champion. Als Weltmarktführer in der Protonentherapie und intimer Kenner der gesamten radiopharmazeutischen Wertschöpfungskette dürfte Ion Beam Applications mittel- bis langfristig von der Kommerzialisierung dieser neuartigen Therapien profitieren....